Seeking Alpha
 

Implant Sciences Corp. (IMSC)

- OTCQB
  • Oct. 1, 2014, 4:34 PM
    • Implant Sciences (OTCQB:IMSC +0.8%) financial results:
    • Fiscal Q4: Revenues: $1.5M (-36.3%); Operating Expenses: $3.6M (-23.4%); Net Loss: ($5.7M) (-2.8%); Loss Per Share: ($0.09) (+10.0%); Quick Assets: $0.4M (+388.8%).
    • Fiscal 2014: Revenues: $8.6M (-28.8%); Operating Expenses: $16.2M (-36.3%); Net Loss: ($21.0M) (+23.2%); Loss Per Share: ($0.35) (+37.5%).
    • No financial guidance given.
    | Comment!
  • Sep. 30, 2013, 5:04 PM
    • Implant Sciences (IMSC.PK): FQ4 EPS of -$0.10 misses by $0.01.
    • Revenue of $2.4M in-line. (PR)
    | Comment!
  • Jun. 14, 2013, 1:43 PM
    Shares of Implant Sciences (IMSC.PK +6.5%) post solid gains on the session. In a still-embargoed article published this morning, SA Pro contributor Inefficient Market calls the stock "a compelling buying opportunity with an attractive asymmetric risk/reward."
    | Comment!
Visit Seeking Alpha's
IMSC vs. ETF Alternatives
Company Description
Implant Sciences Corporation designs, manufactures, and sells explosives trace detection (ETD) and drugs trace detection solutions for multiple security applications including aviation, transportation, customs, air cargo, critical infrastructure protection, ports and borders, force protection,... More
Sector: Technology
Country: United States